Tyra Biosciences Inc - TYRA Income before deduction of interest, taxes and amortization

Graphic logo of tyra.bio (TYRA)

Management's expertise in molecular modeling drives the upward trend, where EBITDA demonstrates growth dynamics. This is supported by the SNAP platform for combating resistance and massive demand for next-generation inhibitors. The value of 0.00 reflects the latest metric value, capturing the current financial result of the commercial activities of Tyra Biosciences, Inc. (TYRA).

Tyra Bio - TYRA Operating profit EBITDA (period 11/23/2025 - 11/14/2026)

Tyra Biosciences Inc (TYRA) - metric breakdowns and financial figures

- market value and analyst target forecast:
Market Price Tyra Biosciences|TYRA - Consensus Target
- issuer market value details:
Market Value Tyra Bio|TYRA - Real Price to Acquire Entire Company
- book capitalization information:
Book Price of a Share Tyra Biosciences|TYRA - Book Capitalization|Market Capitalization to Book Value Ratio tyra.bio|TYRA - Aggregate Company Assets
- company total debt and liquidity indicators:
All Debt to Shareholders' Equity Ratio Tyra Biosciences, Inc.|TYRA - Long-Term Debt to Capital|Short-Term Indebtedness to Equity Tyra Bio|TYRA - Company Aggregate Debts|Debts to Book Value Tyra Bio|TYRA - Company Long-Term Liabilities|Amount of Current Liabilities Tyra Biosciences|Immediate Liquidity tyra.bio
- financial results and valuation multiples details:
TYRA - Net Profit|Net Profit Forecast Tyra Biosciences, Inc.|TYRA - Price to Earnings Ratio|Future Price to Earnings Multiple Tyra Bio|TYRA - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Tyra Biosciences, Inc.|TYRA - Operating profit EBITDA|Earnings per share for the trailing year Tyra Biosciences|TYRA - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months tyra.bio|TYRA - Earnings per share growth in current year|Expected earnings per share trend next year Tyra Biosciences, Inc.
- sales revenue and business income indicators:
TYRA - Revenue and Sales Volume|Projected Sales Volume tyra.bio|TYRA - Price-to-Revenue Ratio|Future Price to Revenue Tyra Bio
Summary company analytics:Tyra Biosciences, Inc.
Brand item of Tyra Biosciences

The indicator is calculated as daily cash flow from operating activities, adjusted for non-cash charges and interest. This metric provides continuous monitoring of operational efficiency between quarterly reports, eliminating the risk of sudden drawdowns. For Tyra Biosciences, Inc. (TYRA), this is a critical tool for controlling R&D costs during the development of FGFR inhibitors. By analyzing the EBITDA_Co trend on the GURU.Markets platform, investors can assess the capital burn rate ahead of key FDA milestones.

Competitor analysis for Tyra Biosciences, Inc.

Genmab (GMAB) - Profit before interest, taxes and amortization|EXEL: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization NUVL (Nuvalent Corp)|KYMR (Kymera) - Operating profit before deduction of amortization|IDYA: Company profit before taxes, interest and amortization|ELVN (Enliven Corp) - Operating profit EBITDA|Operating profit EBITDA oricpharma.com|Profit before payment of interest, taxes and amortization Relay Therapeutics, Inc. (RLAY)|NRIX (Nurix Therapeutics, Inc.) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA VSTM (Verastem Oncology)|Operating profit before depreciation charges Monte Rosa Tx|Cullinan Oncology - Operating profit EBITDA|Profit before interest, taxes and amortization Immuneering|CCCC (C4 Therapeutics, Inc.) - Operating profit before deduction of amortization|BDTX: Company profit before taxes, interest and amortization|RPTX (reparerx.com) - Operating profit EBITDA|Profit before interest, taxes and amortization PMV Pharma PMVP|Operating profit EBITDA KPTI|Propanc Biopharma, Inc. - Operating profit before amortization|Bio Green Med Solution - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization AADI|ALRN: Operating profit before deduction of amortization|blueprintmedicines.com - Company profit before taxes, interest and amortization|GLYC: Operating profit EBITDA|SpringWorks Therapeutics - Income before deduction of interest, taxes and amortization